Thomson Medical Group Full Year 2024 Earnings: Misses Expectations

Thomson Medical Group (SGX:A50) Full Year 2024 Results

Key Financial Results

• Revenue: S$382.7m (up 6.1% from FY 2023).
• Net income: S$15.4m (down 58% from FY 2023).
• Profit margin: 4.0% (down from 10% in FY 2023). The decrease in margin was driven by higher expenses.
• EPS: S$0.001 (in line with FY 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Thomson Medical Group Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 13%. Earnings per share (EPS) also missed analyst estimates by 42%.

Looking ahead, revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Healthcare industry in Asia.

Performance of the market in Singapore.

The company's shares are up 4.2% from a week ago.

Risk Analysis

Don't forget that there may still be risks. For instance, we've identified 2 warning signs for Thomson Medical Group (1 doesn't sit too well with us) you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.